OMERS Administration Corp’s Quest Diagnostics DGX Stock Holding History

OMERS Administration Corp’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Sell	6,614 -5,026	-43%	-$986K	0.01%	632
2026 Q1	$2.28M	Buy	11,640 +10,073	+643%	+$1.96M	0.01%	480
2025 Q4	$272K	Buy	+1,567	New	+$285K	﹤0.01%	834
2017 Q4	–	Sell	-29,793	Closed	-$2.79M	–	420
2017 Q3	$2.79M	Buy	29,793 +15,100	+103%	+$1.6M	0.03%	229
2017 Q2	$1.63M	Buy	+14,693	New	+$1.55M	0.02%	252
2016 Q4	–	Sell	-57,700	Closed	-$4.88M	–	383
2016 Q3	$4.88M	Hold	57,700	–	–	0.09%	148
2016 Q2	$4.7M	Buy	+57,700	New	+$4.39M	0.1%	151
2014 Q3	–	Sell	-4,300	Closed	-$252K	–	363
2014 Q2	$252K	Buy	+4,300	New	+$252K	0.01%	349

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

OMERS Administration Corp's DGX Position: Q2 2026 in Review

OMERS Administration Corp reduced its Quest Diagnostics (DGX) stake by 43% in Q2 2026, selling an estimated $986K and leaving 6,614 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #632.

OMERS Administration Corp first reported a position in DGX in Q2 2014 and has held it in 8 quarters since. The position peaked at $4.88M in Q3 2016. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

OMERS Administration Corp held 6,614 shares of Quest Diagnostics worth $1.4M as of Q2 2026.
OMERS Administration Corp sold 5,026 Quest Diagnostics shares in Q2 2026, an estimated $986K.
Quest Diagnostics made up 0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #632 holding.
OMERS Administration Corp first reported a position in Quest Diagnostics in Q2 2014 and has held it in 8 quarters since.
OMERS Administration Corp's Quest Diagnostics position peaked at $4.88M in Q3 2016.
1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.